Earlier in the spring, the MOT program revealed that in Finland, the life expectancy for certain types of cancer is shorter than in other Nordic countries. The diagnosis is received more slowly, and the approval process for new medications takes longer than in comparable countries. This cannot be the case. This issue simply needs to be corrected. (translated)


